Literature DB >> 32761325

The Rise and Fall of High-Dose Biotin to Treat Progressive Multiple Sclerosis.

Carolyn H Goldschmidt1, Jeffrey A Cohen2.   

Abstract

Entities:  

Keywords:  Biotin; MS relapse; multiple sclerosis; progressive MS

Mesh：

Substances：

Year:  2020        PMID： 32761325      PMCID： PMC7609671          DOI： 10.1007/s13311-020-00907-5

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN： 1878-7479            Impact factor:   7.620


× No keyword cloud information.
  5 in total

1.  Severe transient myopathy in a patient with progressive multiple sclerosis and high-dose biotin.

Authors:  Elisabeth Maillart; Fanny Mochel; Cécile Acquaviva; Thierry Maisonobe; Bruno Stankoff
Journal:  Neurology       Date:  2019-04-26       Impact factor: 9.910

2.  Biotin supplementation in MS clinically valuable but can alter multiple blood test results.

Authors:  Ursela Siddiqui; Emily Egnor; Jacob A Sloane
Journal:  Mult Scler       Date:  2016-12-07       Impact factor: 6.312

3.  [Structure of the muscularis propria on the passage from the small intestine to Meckel's diverticulum].

Authors:  W Reck
Journal:  Anat Anz       Date:  1971

4.  Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.

Authors:  Xavier Montalban; Stephen L Hauser; Ludwig Kappos; Douglas L Arnold; Amit Bar-Or; Giancarlo Comi; Jérôme de Seze; Gavin Giovannoni; Hans-Peter Hartung; Bernhard Hemmer; Fred Lublin; Kottil W Rammohan; Krzysztof Selmaj; Anthony Traboulsee; Annette Sauter; Donna Masterman; Paulo Fontoura; Shibeshih Belachew; Hideki Garren; Nicole Mairon; Peter Chin; Jerry S Wolinsky
Journal:  N Engl J Med       Date:  2016-12-21       Impact factor: 91.245

5.  Tardive Reactivation of Progressive Multiple Sclerosis During Treatment with Biotin.

Authors:  Alexis Demas; Jean-Philippe Cochin; Clémence Hardy; Yvan Vaschalde; Bertrand Bourre; Pierre Labauge
Journal:  Neurol Ther       Date:  2019-12-19
  5 in total
  3 in total

Review 1.  Central nervous system macrophages in progressive multiple sclerosis: relationship to neurodegeneration and therapeutics.

Authors:  Emily Kamma; Wendy Lasisi; Cole Libner; Huah Shin Ng; Jason R Plemel
Journal:  J Neuroinflammation       Date:  2022-02-10       Impact factor: 8.322

Review 2.  Hormone Immunoassay Interference: A 2021 Update.

Authors:  Khaldoun Ghazal; Severine Brabant; Dominique Prie; Marie-Liesse Piketty
Journal:  Ann Lab Med       Date:  2022-01-01       Impact factor: 3.464

Review 3.  New Insights into Multiple Sclerosis Mechanisms: Lipids on the Track to Control Inflammation and Neurodegeneration.

Authors:  Maria Podbielska; Joan O'Keeffe; Anna Pokryszko-Dragan
Journal:  Int J Mol Sci       Date:  2021-07-07       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.